Month: June 2021

REMINDER: Salarius Pharmaceuticals to Host Virtual Key Opinion Leader and Investor Event

Back

REMINDER: Salarius Pharmaceuticals to Host Virtual Key Opinion Leader and Investor Event

Read More

Salarius Pharmaceuticals Announces New Clinical Trial to Study Seclidemstat in Hematologic Cancers

Back

Salarius Pharmaceuticals Announces New Clinical Trial to Study Seclidemstat in Hematologic Cancers

Read More

Salarius Pharmaceuticals to Host Virtual Key Opinion Leader and Investor Event

Back

Salarius Pharmaceuticals to Host Virtual Key Opinion Leader and Investor Event

Read More

Salarius Pharmaceuticals Presents New Research Data Demonstrating Seclidemstat’s Safety, Dosing, and Drug Activity at American Society of Clinical Oncology (ASCO) 2021 Annual Meeting

Back

Salarius Pharmaceuticals Presents New Research Data Demonstrating Seclidemstat’s Safety, Dosing, and Drug Activity at American Society of Clinical Oncology (ASCO) 2021 Annual Meeting

Read More